The p53 proto-oncogene can act as a suppressor of transformation

A new technique for the assay of infectivity of human adenovirus 5 DNA

Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,302

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948

Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes

Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Southern, P. J., & Berg, P. R. (1982) · PubMed · Cited by 2,740

T antigen is bound to a host protein in SY40-transformed cells

Lane, D. P., & Crawford, L. V. (1979) · Nature · doi:10.1038/278261a0 · Cited by 2,456

Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells

Linzer, D. I. H., & Levine, A. J. (1979) · Cell · doi:10.1016/0092-8674(79)90293-9 · Cited by 1,814

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J.-Y., Huang, C.-M., Lee, W.-H., Marsilio, E., Paucha, E., & Livingston, D. M. (1988) · Cell · doi:10.1016/0092-8674(88)90559-4 · Cited by 1,459

Human Retinoblastoma Susceptibility Gene: Cloning, Identification, and Sequence

Lee, W., Bookstein, R., Hong, F., Young, L.-J., Shew, J., & Lee, E. Y.-H. P. (1987) · Science · doi:10.1126/science.3823889 · Cited by 1,417

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

Whyte, P., Buchkovich, K. J., Horowitz, J. M., Friend, S. H., Raybuck, M., Weinberg, R. A., & Harlow, E. (1988) · Nature · doi:10.1038/334124a0 · Cited by 1,403

Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture

Ruley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248

Transformation and Radiosensitivity of Human Diploid Skin Fibroblasts Transfected with SV40 T-antigen Mutants Defective in RB and P53 Binding Domains

Su, L.-N., & Little, J. B. (1992) · International Journal of Radiation Biology · doi:10.1080/09553009214552341 · Cited by 35

p53 Codon 72 Polymorphism Interactions with Dietary and Tobacco Related Habits and Risk of Stomach Cancer in Mizoram, India

Malakar, M., Devi, K. R., Phukan, R. K., Kaur, T., Deka, M., Puia, L., Sailo, L., Lalhmangaihi, T., Barua, D., Rajguru, S. K., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.717 · Cited by 35

TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors

Kim, J., Jung, J., Kim, K., Lee, J., & Im, Y. (2023) · Cancer Medicine · doi:10.1002/cam4.5953 · Cited by 36

ANX7 as a Bio‐Marker in Prostate and Breast Cancer Progression

Srivastava, M., Bubendorf, L., Nolan, L., Glasman, M., Leighton, X., Miller, G., Fehrle, W., Raffeld, M. A., Eidelman, O., Kallioniemi, O., et al. (2001) · Disease Markers · doi:10.1155/2001/239602 · Cited by 34

Roles of estrogen receptor, progesterone receptor, p53 and p21 in pathogenesis of pelvic organ prolapse

Bai, S. W., Chung, D. J., Yoon, J. M., Shin, J. S., Kim, S. K., & Park, K. H. (2005) · International Urogynecology Journal · doi:10.1007/s00192-005-1310-9 · Cited by 34

Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder

Kamel, D., Pääkkö, P. K., Pöllänen, R., Vähäkangas, K., Lehto, V., & Soini, Y. (1995) · Apmis · doi:10.1111/j.1699-0463.1995.tb01116.x · Cited by 34

Wild-Type p53 Attenuates Cancer Cell Motility by Inducing Growth Differentiation Factor-15 Expression

Cheng, J., Chang, H., & Leung, P. C. K. (2011) · Endocrinology · doi:10.1210/en.2011-0059 · Cited by 34

Between Scylla and Charybdis: p53 links tumor suppression and aging

Campisi, J. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00006-4 · Cited by 33

Neomorphic mutations create therapeutic challenges in cancer

Takiar, V., Ip, C. K. M., Gao, M., Mills, G. B., & Cheung, L. W. T. (2016) · Oncogene · doi:10.1038/onc.2016.312 · Cited by 33

Novel tertiary sulfonamides as potent anti-cancer agents

Okolotowicz, K. J., Dwyer, M., Ryan, D., Cheng, J., Cashman, E. A., Moore, S., Mercola, M. A., & Cashman, J. R. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.07.042 · Cited by 33

Multilevel regulation and molecular mechanism of poly (rC)‐binding protein 1 in cancer

Zhang, X., Di, C., Chen, Y., Wang, J., Su, R., Huang, G., Xu, C., Chen, X., Long, F., Yang, H., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000911r · Cited by 33

Chmp 1A is a mediator of the anti-proliferative effects of All-trans Retinoic Acid in human pancreatic cancer cells

Li, J., Orr, B., White, K., Belogortseva, N., Niles, R. M., Bošković, G., Nguyen, H., Dykes, A. C., & Park, M. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-7 · Cited by 33

p53 tumor suppressor gene mutations in transformed cutaneous T‐cell lymphoma: A study of 12 cases

Marrogi, A. J., Khan, M. A., Vonderheid, E. C., Wood, G. S., & McBurney, E. I. (1999) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.1999.tb01860.x · Cited by 33

Point mutations of the P53 gene, human hepatocellular carcinoma and aflatoxins

Gerbes, A. L., & Caselmann, W. H. (1993) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80587-2 · Cited by 33

p53 expression in carcinoma of the cervix.

Hunt, C. R., Hale, R., BUCKLEY, C. H., & Hunt, J. (1996) · Journal of Clinical Pathology · doi:10.1136/jcp.49.12.971 · Cited by 33

Inhibition of Stress-Inducible Kinase Pathways by Tumorigenic Mutant p53

Ohiro, Y., Usheva, A., Kobayashi, S., Duffy, S., Nantz, R., Gius, D. R., & Horikoshi, N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.322-334.2003 · Cited by 33

Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions

Moretti, S., Pinzi, C., Spallanzani, A., Berti, E., Chiarugi, A., Mazzoli, S., Fabiani, M., Vallecchi, C., & Herlyn, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990420)84:2 · Cited by 98

Immunostaining of p53 protein in ovarian carcinoma: correlation with histopathological data and clinical outcome

Reles, A., Schmider, A., Press, M. F., Sch�nborn, I., Friedmann, W. G., Huber-Schumacher, S., Strohmeyer, T. G., & Lichtenegger, W. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01187161 · Cited by 33

Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours

Lemoine, N. R., Hughes, C. M., & Cowell, J. K. (1992) · The Journal of Pathology · doi:10.1002/path.1711680213 · Cited by 33

Inhibition of Cell Growth by Transforming Growth Factor β1 Is Associated with p53‐Independent Induction of p21 in Gastric Carcinoma Cells

Akagi, M., Yasui, W., Akama, Y., Yokozaki, H., Tahara, H., Haruma, K., Kajiyama, G., & Tahara, E. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb00233.x · Cited by 33

Prostate Cancer: A Clinical and Basic Science Review

LONG, R. J., Roberts, K. P., Wilson, M. J., Ercole, C. J. J., & Pryor, J. L. (1997) · Journal of Andrology · doi:10.1002/j.1939-4640.1997.tb01871.x · Cited by 33

The polymerase chain reaction and cancer diagnostics

Lyons, J. F. (1992) · Cancer · doi:10.1002/1097-0142(19920315)69:6+ · Cited by 12

Absence of overexpression of p53 protein by intestinal carcinoid tumours

O'Dowd, G., & Gosney, J. R. (1995) · The Journal of Pathology · doi:10.1002/path.1711750407 · Cited by 33

Altered expression of wild-type p53 tumor suppressor gene during murine epithelial cell transformation.

Han, K., & Kulesz-Martin, M. F. (1992) · PubMed · Cited by 33

The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation.

Yehiely, F., & Oren, M. (1992) · PubMed · Cited by 33

Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer

Uchida, Τ., Wada, C., Shitara, T., Egawa, S., & Koshiba, K. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.423 · Cited by 33

Are tumours immortal?

Stamps, A. C., Gusterson, B. A., & O’Hare, M. J. (1992) · European Journal of Cancer · doi:10.1016/0959-8049(92)90552-d · Cited by 33

Programmed cell death 6, a novel p53‐responsive gene, targets to the nucleus in the apoptotic response to DNA damage

Suzuki, K., Dashzeveg, N. K., Lu, Z., Taira, N., Miki, Y., & Yoshida, K. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02362.x · Cited by 32

Inhibitors of MDM2 and MDMX: A Structural Perspective

Riedinger, C., & McDonnell, J. M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.75 · Cited by 32

Combination analysis of Bub1 and Mad2 expression in endometrial cancer: act as a prognostic factor in endometrial cancer

Li, L., Xu, D., Zhao, X., & Hao, T. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2706-7 · Cited by 32

Exploring the p53 connection of cervical cancer pathogenesis involving north-east Indian patients

Khan, M. A., Tiwari, D., Dongre, A., Sadaf, S., Mustafa, S., Das, C. R., Massey, S., Bose, P. D., Bose, S., & Husain, S. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238500 · Cited by 32

Prognostic Value of Mdm2, p53 and p16 in Patients with Astrocytomas

Ranuncolo, S. M., Varela, M. S., Morandi, A., Lastiri, J. M., Christiansen, S. B., Joffé, E. B. D. K., Pallotta, M. G., & Puricelli, L. (2004) · Journal of Neuro-Oncology · doi:10.1023/b:neon.0000027741.19213.99 · Cited by 32

Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma

Hsu, H., Huang, A., Lai, P., Chien, W., Peng, S., & Lin, S. (1994) · Hepatology · doi:10.1002/hep.1840190120 · Cited by 32

Role of p53 in leukemogenesis of chronic myeloid leukemia

Lanza, F., & Bi, S. (1995) · Stem Cells · doi:10.1002/stem.5530130416 · Cited by 32

Clinicopathological and molecular biological studies of gastric adenomas with special reference to p53 abnormality

Sakurai, S., Sano, T., & Nakajirna, T. (1995) · Pathology International · doi:10.1111/j.1440-1827.1995.tb03379.x · Cited by 32

Tumor Suppressor Genes and Human Cancer

Brown, M. A. (1997) · Advances in genetics · doi:10.1016/s0065-2660(08)60307-7 · Cited by 32

p53 immunoreactivity in hepatocellular adenoma, focal nodular hyperplasia, cirrhosis and hepatocellular carcinoma

Ojanguren, I., Ariza, A., Castellà, E., Fernández‐Vasalo, A., Mate, J. L., & Navas‐Palacios, J. J. (1995) · Histopathology · doi:10.1111/j.1365-2559.1995.tb00622.x · Cited by 32

Hot-Spot p53 Mutants Interact Specifically with Two Cellular Proteins during Progression of the Cell Cycle

Chen, Y., Chen, P., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6764 · Cited by 32

Effects of 1,25 Dihydroxyvitamin D3 and Calcium on Growth and Differentiation and on c-fos and p53 Gene Expression in Normal Human Keratinocytes

Sébag, M., Gulliver, W. P. F., & Kremer, R. B. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12394802 · Cited by 32

Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia

Zhang, W., Hu, G., & Deisseroth, A. (1992) · Gene · doi:10.1016/0378-1119(92)90738-b · Cited by 32

Immunohistochemical detection of p53 protein in archival tissues from squamous cell carcinomas of the oral cavity using wet autoclave antigen retrieval

Piffkò, J., Bánkfalvi, Á., Öfner, D., Joos, U., Böcker, W., & Schmid, K. W. (1995) · The Journal of Pathology · doi:10.1002/path.1711760111 · Cited by 32

Oncogenes: cause or consequence in the development of glial tumors

Akbaşak, A., & Akbaşak, B. S. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90060-x · Cited by 31

Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression

Crook, T., Fisher, C., & Vousden, K. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.505-510.1991 · Cited by 32

Polymorphisms inGSTT1andp53and urinary transitional cell carcinoma in south-western Taiwan: A preliminary study

Chen, Y., Xu, L.-L., Guo, Y. L., Su, H.-J. J., Smith, T. J., RYAN, L. M., Lee, M.-S., & Christiani, D. C. (2004) · Biomarkers · doi:10.1080/13547500400010122 · Cited by 31

RAD6 Regulates the Dosage of p53 by a Combination of Transcriptional and Posttranscriptional Mechanisms

Chen, S., Wang, D.-L., Liu, Y., Zhao, L., & Sun, F.-L. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05966-11 · Cited by 34

Analysis of TP53 and PTEN in gliomatosis cerebri

Mawrin, C., Kirches, E., Schneider‐Stock, R., Scherlach, C., Vorwerk, C. K., von Deimling, A., van Landeghem, F. K. H., Meyermann, R., Bornemann, A., Müller, A., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0674-5 · Cited by 31

p53 Protein Overexpression: A Strong Prognostic Factor in Uterine Papillary Serous Carcinoma

Bancher‐Todesca, D., Gitsch, G., Williams, K. E., Kohlberger, P., Neunteufel, W., Obermair, A., Heinze, G., Breitenecker, G., & Hacker, N. F. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5113 · Cited by 31

Initiators and Promoters of Lung Cancer

Mulshine, J. L., Treston, A. M., Brown, P. H., Birrer, M. J., & Shaw, G. L. (1993) · CHEST Journal · doi:10.1378/chest.103.1.4s · Cited by 31

TP53 mutations in stage I gallbladder carcinoma with special attention to growth patterns

Hanada, K., Itoh, M., Fujii, K., Tsuchida, A., Hirata, M., Iwao, T., Eguchi, N., Sasaki, T., Matsubara, K., & Kajiyama, G. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00080-4 · Cited by 31

An increased relative frequency of retinoblastoma at a rural regional referral hospital in Miraj, Maharashtra, India

Schultz, K. R., Ranade, S., Neglia, J. P., & Ravindranath, Y. (1993) · Cancer · doi:10.1002/1097-0142(19930701)72:1 · Cited by 50

Heterogeneous expression of proto‐oncogenes in Hodgkin's disease derived cell lines

Jücker, M., Schaadt, M., Diehl, V., Poppema, S., Jones, D. B., & Tesch, H. (1990) · Hematological Oncology · doi:10.1002/hon.2900080404 · Cited by 31

Expression of proliferating cell nuclear antigen, Ki‐67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: An immunochemical study with clinical, pathobiological, and histologic correlations

Pelosi, G., Bresaola, E., Rodella, S., Manfrin, E., Piubello, Q., Schiavon, I., & Lannucci, A. (1994) · Diagnostic Cytopathology · doi:10.1002/dc.2840110206 · Cited by 31

Tumor suppressor genes in the cell cycle

Sager, R. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90026-9 · Cited by 31

Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines

Farshid, M., & Tabor, E. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890380402 · Cited by 31

p53 Mutations Occur in Clinical, but Not Latent, Human Prostate Carcinoma

Konishi, N., Hiasa, Y., Hayashi, I., Matsuda, H., Tsuzuki, T., Tao, M., Kitahori, Y., Shiraishi, T., Yatani, R., & Shimazaki, J. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb02988.x · Cited by 31

Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.

Aoyama, N., Nagase, T., Sawazaki, T., Mizuguchi, G., Nakagoshi, H., Fujisawa, J., Yoshida, M., & Ishii, S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5403 · Cited by 31

Overexpression of p53 protein in human tumors

Inoue, K., Kurabayashi, A., Shuin, T., Ohtsuki, Y., & Furihata, M. (2012) · Medical Molecular Morphology · doi:10.1007/s00795-012-0575-6 · Cited by 29

Growing Recognition of the Role for Rare Missense Substitutions in Breast Cancer Susceptibility

Tavtigian, S. V., & Chenevix‐Trench, G. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.13.143 · Cited by 29

Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells

Bungsy, M., Palmer, M. C. L., Jeusset, L. M., Neudorf, N. M., Lichtensztejn, Z., Nachtigal, M. W., & McManus, K. J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.051 · Cited by 34

p53: a molecular marker for the detection of cancer

Boyd, M. T., & Vlatković, N. (2008) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2.9.1013 · Cited by 30

Overexpression of genes in health and sickness. A bird's eye view

Shastry, B. S. (1995) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/0305-0491(95)00055-d · Cited by 30

Insulin receptor-independent upregulation of cellular glucose uptake

Krishnapuram, R., Kirk-Ballard, H., Dhurandhar, E. J., Dubuisson, O. S., Messier, V., RABASA-LHORET, R. P. R., Hegde, V. K., Aggarwal, S., & Dhurandhar, N. V. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.6 · Cited by 30

Expression Patterns of Cellular Growth-Controlling Genes in Non-Medullary Thyroid Cancer: Basic Aspects

Sarlis, N. J. (2000) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010079031162 · Cited by 30

Effects of Exogenous p53 Transduction in Thyroid Tumor Cells with Different p53 Status1

Moretti, F., Nanni, S., Farsetti, A., Narducci, M. L., Crescenzi, M., Giuliacci, S., Sacchi, A., & Pontecorvi, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6295 · Cited by 30

p53 tumor suppressor gene protein expression in cervical cancer: relationship to prognosis

Bremer, G. L., Tieboschb, A. T. M. G., van der Putten, H. W. H. M., de Haan, J., & Arends, J. (1995) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0301-2115(95)02225-v · Cited by 30

Li-Fraumeni Syndrome and the Role of the p53 Tumor Suppressor Gene in Cancer Susceptibility

AKASHI, M., & Koeffler, H. P. (1998) · Clinical Obstetrics & Gynecology · doi:10.1097/00003081-199803000-00024 · Cited by 30

Early Region 1 Transforming Functions Are Dispensable for Mammary Tumorigenesis by Human Adenovirus Type 9

Thomas, D. L., Shin, S., Jiang, B. H., Vogel, H. S., Ross, M. A., Kaplitt, M. G., Shenk, T. E., & Javier, R. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.3071-3079.1999 · Cited by 30

Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression

Qi, J.-S., Desai-Yajnik, V., Yuan, Y., & Samuels, H. H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7195 · Cited by 30

Molecular epidemiology of human cancer

Hussain, S. P., & Harris, C. C. (1998) · Toxicology Letters · doi:10.1016/s0378-4274(98)00310-5 · Cited by 30

Inhibition of DNA synthesis by TGF-β1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein

Suzuki, K., Ono, T., & Takahashi, K. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80314-6 · Cited by 30

Phenotype modulation of human adult fibroblasts by oncogenes

Kopelovich, L., & Demian, S. E. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199603)15:3 · Cited by 3

Direct growth stimulation of normal human epithelial cells by mutant p53

Wyllie, F. S., Lemoine, N. R., Barton, C. M., Dawson, T., BOND, J. A., & Wynford‐Thomas, D. (1993) · Molecular Carcinogenesis · doi:10.1002/mc.2940070205 · Cited by 30

Histologic grade and p53 immunoreaction as indicators of early recurrence of node-negative breast cancer

Iwaya, K. (1997) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/27.1.6 · Cited by 30

An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes

Campbell, A. E., Slater, J. S., Cavanaugh, V. J., & Stenberg, R. M. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3011-3017.1992 · Cited by 30

Two α-dicarbonyls downregulate migration, invasion, and adhesion of liver cancer cells in a p53-dependent manner

Loarca, L., Sassi‐Gaha, S., & Artlett, C. M. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.05.005 · Cited by 29

MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?

Azer, S. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7040064 · Cited by 27

Establishment of TP53-knockout canine cells using optimized CRIPSR/Cas9 vector system for canine cancer research

Eun, K., Park, M. G., Jeong, Y. W., Jeong, Y. I., Hyun, S., Hwang, W. S., Kim, S.-H., & Kim, H. (2019) · BMC Biotechnology · doi:10.1186/s12896-018-0491-5 · Cited by 30

Neurogenic differentiation factor 1 promotes colorectal cancer cell proliferation and tumorigenesis by suppressing the p53/p21 axis

Lei, K., Li, W., Huang, C., Li, Y., Alfason, L., Zhao, H., Miyagishi, M., Wu, S., & Kasim, V. (2019) · Cancer Science · doi:10.1111/cas.14233 · Cited by 29

The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53

Li, W., Herkilini, A., Tang, Y. R., Huang, P. C., Song, G., Miyagishi, M., Kasim, V., & Wu, S. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00599-9 · Cited by 30

p53 and chemosensitivity in bladder cancer

Nishiyama, H., Watanabe, J., & Ogawa, O. (2008) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0815-x · Cited by 28

Comparative study of the expression of Rb and p53 genes in human colorectal cancers, colon carcinoma cell lines and synchronized human fibroblasts

Gope, M. L., Chun, M., & Gope, R. (1991) · Molecular and Cellular Biochemistry · doi:10.1007/bf02424576 · Cited by 29

Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas

Ohashi, K., Nemoto, T., Eishi, Y., Matsuno, A., Nakamura, K., & Hirokawa, K. (1997) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01008031 · Cited by 29

p21(WAF1/Cip1) retards the growth of human squamous cell carcinomas in vivo

Cardinali, M., Jakus, J., Shah, S., Ensley, J. F., Robbins, K. C., & Yeudall, W. A. (1998) · Oral Oncology · doi:10.1016/s1368-8375(97)00083-3 · Cited by 29

p53 Overexpression and Mutation in Endometrial Carcinoma: Inverted Relation with Estrogen and Progesterone Receptor Status

Niwa, K., Murase, T., Morishita, S., Hashimoto, M., Itoh, N., & Tamaya, T. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.09909.x · Cited by 29

Genetic basis of susceptibility to melanoma

Piepkorn, M. W. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70274-8 · Cited by 29

In search of the functions of normal p53 protein

Rotter, V., Foord, O., & Navot, N. (1993) · Trends in Cell Biology · doi:10.1016/0962-8924(93)90151-p · Cited by 29

Frequent P53 mutation in mouse tumors induced by repeated β‐irradiation

Ootsuyama, A., Makino, H., Nagao, M., Ochiai, A., Yamauchi, Y., & Tanooka, H. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110409 · Cited by 29

BARRETT'S ESOPHAGUS

Reynolds, J. C., Waronker, M., Pacquing, M. S., & Yassin, R. R. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70098-4 · Cited by 29

p53 mutation without allelic loss and absence of mdm‐2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters

Okita, S., Tsutsumi, M., Onji, M., & Konishi, Y. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940130409 · Cited by 29

SH2 mutants of c-src that are host dependent for transformation are trans-dominant inhibitors of mouse cell transformation by activated c-src.Preprint

Hirai, H., & Varmus, H. E. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2342 · Cited by 29

The levels of p53 govern the hierarchy of DNA damage tolerance pathway usage

Castaño, B. A., Schorer, S., Guo, Y., Calzetta, N. L., Gottifredi, V., Wiesmüller, L., & Biber, S. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae061 · Cited by 29

EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis

Mori, J., Tanikawa, C., Ohnishi, N., Funauchi, Y., Toyoshima, O., Ueda, K., & Matsuda, K. (2017) · Neoplasia · doi:10.1016/j.neo.2016.12.010 · Cited by 28

Association between TP53 gene Arg72Pro polymorphism and Wilms’ tumor risk in a Chinese population

Fu, W., Zhuo, Z., Jia, W., Zhu, J., Zhu, S., Lin, Z., Wang, F., Xia, H., He, J., & Liu, G. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s131014 · Cited by 28

The Intricate Role of p53 in Adipocyte Differentiation and Function

Lee, Y. K., Chung, Y. S., Lee, J. H., Chun, J. M., & Park, J. H. (2020) · Cells · doi:10.3390/cells9122621 · Cited by 29

Shifting the paradigms for tumor suppression: lessons from the p53 field

Barnoud, T., Indeglia, A., & Murphy, M. E. (2021) · Oncogene · doi:10.1038/s41388-021-01852-z · Cited by 31

p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan

Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2

Undiagnosed malignancy in patients with deep vein thrombosis: incidence, risk indicators, and diagnosis

(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0142(19980701)83:1 · Cited by 3

Hot flashes in postmenopausal women treated for breast carcinoma

Carpenter, J. S., Andrykowski, M. A., Cordova, M., Cunningham, L., Studts, J., McGrath, P., Kenady, D., Sloan, D., & Munn, R. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980501)82:9

The properties of p53 proteins selected for the loss of suppression of transformation.

Olson, D., & Levine, A. J. (1994) · PubMed · Cited by 23

Wild-type p53 can inhibit oncogene-mediated focus formation.

Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 687

The p53 tumor suppressor gene and gene product.

Levine, A. J. (1989) · PubMed · Cited by 57

Transcriptional Activation by Wild-Type but Not Transforming Mutants of the p53 Anti-Oncogene

Raycroft, L., Wu, H., & Lozano, G. (1990) · Science · doi:10.1126/science.2144364 · Cited by 620

Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

Hinds, P. W., Finlay, C. A., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 595